Alaron 10 tablet: Each tablet contains Loratadine USP 10 mg.
Alaron suspension: Each 5 ml contains Loratadine USP 5 mg.
Alaron® is a preparation of Loratadine which is long acting non-sedative anti-histamine with selective peripheral H1 receptor antagonistic activity.
Route: Oral
Adults & children >12 years:
Children 2 to 12 years:
Renal / Hepatic impairment (GFR <30 mL/min):
CYP3A4 and CYP2D6 inhibitors (ketoconazole, erythromycin, cimetidine) increase loratadine plasma concentrations without significant clinical ECG changes; alcohol does not potentiate psychomotor impairment.
Loratadine is contraindicated in patients who have known hypersensitivity or idiosyncrasy to Loratadine or any of its components.
Common: Fatigue, dizziness, dry mouth, headache, sedation, nausea, pruritus.
Overdose
No Data
Category B. Safe use in pregnancy has not been established; use only if potential benefit outweighs fetal risk. Lactation: Loratadine and metabolite are excreted into breast milk; discontinue nursing or discontinue drug.
Store below 30°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.